This company seems to have been delisted
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Vifor Pharma
VIFN.SW
$312.32
Share price
0.48%
Change (1 day)
8.00%
Change (1 year)
Categories
Vifor Pharma (VIFN.SW) - Total liabilities
Total liabilities on the balance sheet as of December 2021 : NZ$2.15 Billion
According to Vifor Pharma's latest financial reports the company's total liabilities are NZ$2.15 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vifor Pharma - Total liabilities on balance sheet (from 2009 to 2021)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2021-12-31 | NZ$1.81 B | -3.51% |
| 2020-12-31 | NZ$1.87 B | 2.14% |
| 2019-12-31 | NZ$1.83 B | 7.23% |
| 2018-12-31 | NZ$1.71 B | 49.4% |
| 2017-12-31 | NZ$1.14 B | -74.14% |
| 2016-12-31 | NZ$4.43 B | 80.3% |
| 2015-12-31 | NZ$2.46 B | 30.73% |
| 2014-12-31 | NZ$1.88 B | -9.38% |
| 2013-12-31 | NZ$2.07 B | -11.85% |
| 2012-12-31 | NZ$2.35 B | -9.76% |
| 2011-12-31 | NZ$2.61 B | -9.33% |
| 2010-12-31 | NZ$2.87 B | 1.27% |
| 2009-12-31 | NZ$2.84 B | 14.72% |
| 2008-12-31 | NZ$2.47 B | 149.7% |
| 2007-12-31 | NZ$0.99 B | 8.73% |
| 2006-12-31 | NZ$0.91 B | 14.18% |
| 2005-12-31 | NZ$0.79 B | -16.02% |
| 2004-12-31 | NZ$0.95 B | -9.35% |
| 2003-12-31 | NZ$1.05 B | -29.66% |
| 2002-12-31 | NZ$1.49 B |